Are We There Yet? Another Milepost in the Journey to Identify Appropriate Candidates for Aspirin Primary Prevention

In their article, Selak and colleagues report sex-specific models to predict risk for major bleeding events in adults without cardiovascular disease who are not receiving antiplatelet therapy. The editorialists discuss the strengths and limitations of these models and why they believe the models offer a major step toward more evidence-based, individualized decision making about aspirin use to prevent cardiovascular disease (and perhaps colorectal cancer).

from A via a.sfakia on Inoreader https://ift.tt/2BSEzut